Taiwan surrogacy law: commercial and altruistic models (2026)
The answer as of 25 October 2026
Taiwan has no operative legal route for a gestational carrier to bear a child for intended parents under its Assisted Reproduction Act. Neither a fee-paying commercial arrangement nor a purportedly altruistic arrangement has been authorised as a regulated Taiwanese assisted-reproduction service. This is an important distinction: the law restricts the conduct of assisted reproduction and the persons to whom it may be supplied; it does not contain a simple standalone criminal offence named “being a surrogate”. Whether particular conduct also attracts a penalty depends on its actual facts and a specific statutory provision. A signed private agreement, a medical indication or a clinic advertisement cannot change that legal position.
Which law governs, and what it actually says
The primary national statute is the Assisted Reproduction Act (人工生殖法), shown in the Ministry of Justice legislative database as last amended on 3 January 2018. Article 2(3) defines the recipient couple as a husband and wife where the wife can gestate and deliver a child using her own uterus. Article 11 imposes conditions on treatment of that recipient couple. Neither provision establishes a category of intended parents using a different woman to carry the pregnancy. The Ministry of Health and Welfare is the central competent authority under Article 3. The operative text, rather than announcements about future reform, controls a proposed procedure today.
Why this is not a licensing pathway for surrogacy
Article 6 requires a medical institution to obtain official permission before carrying out assisted reproduction or handling donated gametes. That permission is not a transferable licence to conduct every type of reproductive service. Article 11 still limits treatment to eligible recipient couples, including the wife’s capacity to carry the pregnancy. Consequently, a facility approved for ordinary IVF cannot treat approval as authorisation to transfer an embryo to a third-party gestational carrier for somebody else. Equally, a clinician’s suggestion that a different adult can consent to carrying the child does not supply the missing statutory treatment route. Ask to see the exact legal basis, not merely a clinic’s licence certificate.
What the existing medical exception does not change
Article 11 provides a limited route for a couple that does not satisfy its infertility-or-serious-hereditary-disease ground but has another medically legitimate reason: treatment may proceed after competent-authority approval. That clause should not be confused with an exception allowing the wife’s gestation requirement to be waived or a surrogate to be substituted. Article 5 excludes a narrowly described procedure—placing a husband’s sperm into his own wife—from much of the Act, subject to the sex-selection rule. It does not exempt arrangements involving a separate carrier. None of these clauses supplies a general compassionate, family-member or medical-hardship exception for surrogacy.
Commercial versus altruistic: the correct classification
“Commercial” generally describes a model in which a carrier is compensated for providing gestational services beyond permissible costs; “altruistic” generally describes a model without a service fee, sometimes with reimbursement of proven expenses. These are useful comparative descriptions, not two Taiwan licensing categories. The relevant question is first whether the underlying assisted-reproduction procedure can lawfully be offered. On the verified statutory text, it cannot be offered as a domestic surrogacy programme under either label. Removing a fee, using a relative or paying only hospital bills does not make an otherwise unavailable procedure authorised. Conversely, one should not invent a blanket crime for every reimbursement or conversation: assess the acts separately.
Decision matrix: what a proposed plan really permits
A standard authorised procedure in which an eligible wife herself gestates is legally distinct from a plan in which a third person carries the embryo. For a paid gestational carrier there is no domestic surrogacy permission; for an unpaid friend or relative there is likewise no separate surrogacy permission. Lawful reimbursement of gamete donors within Article 8 is not remuneration for acting as a gestational carrier. An overseas clinic’s lawful programme is a question for the country where treatment occurs; it does not automatically establish Taiwanese parentage, birth registration or rights on return. The matrix below identifies these separate decisions and prevents a treatment licence from being mistaken for a surrogate agreement licence.
| Proposed route | Legal reading |
|---|---|
| Traditional IVF with the wife giving birth | Potentially permissible when Articles 2, 6, 7, 11 and 12 and other applicable conditions are met; not surrogacy. |
| Unpaid carrier who is a relative or friend | No domestic assisted-reproduction surrogacy pathway is created by lack of payment or kinship. |
| Paid gestational carrier in Taiwan | No domestic permission; examine any particular payments and clinical acts under the relevant provisions. |
| Egg or sperm donor expenses | A distinct limited reimbursement scheme under Article 8; not a carrier-compensation scheme. |
| Treatment abroad and return to Taiwan | Foreign treatment law and later Taiwanese parentage, registration and travel rules require independent checks. |
Gamete donation is a different legal mechanism
Article 8 defines conditions for voluntary sperm and egg donation, including age bands, medical assessment and donation without payment. It also allows the recipient couple, within the competent authority’s limits, to cover specified nutrition, testing, medical, lost-working-time and transport costs for donors. That narrowly defined allowance does not authorise buying reproductive cells or paying a woman to gestate someone else’s child. Article 31 specifically punishes profit-motivated buying, selling or brokering of reproductive cells or embryos; it must not be recast as a universal criminal tariff for surrogacy. Contracts should identify whether an amount is for clinical care, a lawful donation-related cost, brokerage, or gestational services, because the statutory characterisation differs.
Who can use currently regulated assisted reproduction
The Act’s present definition of recipient couple is a husband and wife, with the wife able to carry and give birth. Article 11 additionally addresses clinical assessment, infertility or serious hereditary disease, and the requirement that at least one spouse supplies healthy reproductive cells. There is a separate approval route for another medically justified reason, but it is not permission for a carrier. These rules are relevant to distinguishing ordinary assisted reproduction from surrogacy; this page does not decide a particular foreign applicant’s residence, identity, marriage recognition or donor eligibility. Those factors require individual review before relying on any clinic’s offer. A proposed expansion to other applicants remains a different question from enacted law.
Which conduct may trigger legal consequences
The statute contains differentiated offences and administrative controls, not a single penalty for “surrogacy”. Article 33 provides an administrative fine of NT$100,000 to NT$500,000 for specified breaches, including operating without the permission required by Article 6(1)–(2), accepting a donation contrary to Article 8(1), or violating Article 11. Article 31 provides for imprisonment for up to two years, short-term detention, or a fine of NT$200,000 to NT$1,000,000 for profit-motivated buying, selling or brokering of reproductive cells or embryos; the fine may be imposed alone or cumulatively with a custodial penalty, as the provision permits. Article 30 addresses other specified serious prohibited acts, including particular breaches of Articles 15 and 16, not every surrogacy contract. Article 35 contemplates professional discipline for a doctor committing enumerated breaches; Article 37 addresses certain licence consequences. Any application requires the exact act, actor and charge to be established.
Contracts, consent and private arrangements
A written agreement cannot create legal authorisation for a medical act omitted from the statutory framework. It also cannot guarantee that an intended parent will be registered as a legal parent after birth, or that a carrier’s pregnancy, childbirth, autonomy and medical decisions can be contracted away. The enforceability of individual clauses and any related liability must be assessed under applicable civil, medical and other law rather than assumed from the absence of a surrogacy statute. Before paying an agency, request its legal entity details, the clinic’s actual permission, itemised services, refund rules, custody of genetic material, and a precise statement of which country’s law supposedly authorises each step. Do not rely on a guarantee of a “Taiwan surrogacy certificate”.
Parentage is not automatically assigned to intended parents
Articles 23–25 of the Assisted Reproduction Act deal with the legal status of children born under the recognised framework involving the recipient wife and donated gametes. They do not supply a surrogacy parentage-order mechanism. Ordinary Civil Code rules governing parent-child status may need analysis where a different woman carries and gives birth, but the answer depends on marriage, genetic facts, birth location and the precise proceeding. A payment contract or DNA result by itself is not an automatic Taiwanese parentage decree. Before conception, obtain advice on whose name may appear in the initial civil-status record, the legal options for challenging or establishing parentage, and the child’s interests; do not assume a later administrative correction is guaranteed.
Why a lawful overseas programme needs separate analysis
Some intended parents explore treatment abroad. The legality of fertilisation, embryo transfer, payments to a carrier and agreements is determined under the law of the place where each act occurs; travel by Taiwanese citizens or residents does not itself validate the programme under Taiwanese law. Taiwan’s later treatment of a foreign birth record, court order or genetic link is a separate question. The legality of treatment abroad is not the same as recognition of parentage, and immigration documents do not themselves establish parentage. The carrier’s consent alone is not a travel document. In an interpretation dated 31 July 2026, Taiwan’s Ministry of Justice addressed Taiwanese nationals’ children born in Taiwan following overseas assisted reproduction in an “A-egg/B-birth” arrangement. It said Civil Code Articles 1064–1065 do not apply to the fact patterns considered and referred to the Ministry of Health and Welfare the question whether the Assisted Reproduction Act applies, including by analogy, or requires amendment. This fact-specific administrative interpretation is not a universal parentage ruling for every surrogacy case; it highlights the need for case-specific advice.
Do not conflate birth registration, nationality and travel
A child’s birth certificate records facts under the relevant registration system; it does not alone decide every state’s nationality or parental recognition rules. For an overseas birth, verify the law at the birthplace, the intended parents’ citizenship law, any Taiwanese household-registration or travel-document requirements, and whether the foreign parentage instrument is effective for the requested administrative step. A translated or legalised document may help prove authenticity but does not cure a missing legal basis for parentage. If an agency says “a birth certificate solves everything”, request separate written confirmation from the competent registries and the relevant consular or immigration authority. Do not travel with an assumed entitlement to documents.
Legislative proposals are not permission
On 11 December 2025, the Executive Yuan approved a government draft to amend the Assisted Reproduction Act, including a proposal to expand access for certain unmarried women and married female same-sex couples. As of 25 October 2026, the Legislative Yuan’s official bill record lists the government draft as submitted on 19 December 2025 and still at committee review; its latest listed committee review is dated 16 July 2026. The official agenda records continued review of the government and members’ bills on 16 July; Central News Agency reported that the committee voted that day to separate surrogacy from the amendment bill. The government draft did not establish a surrogacy framework. Cabinet approval, bill submission or committee action is not enactment. The official consolidated Act still shows 3 January 2018 as its last amendment date. Recheck the statute and commencement position immediately before any proposed procedure. A political promise of altruistic surrogacy is not a current authorization.
What documentary evidence to obtain before action
For a domestic offer, ask for the full clinic name and permit details, the precise procedure proposed, where fertilisation and transfer would occur, who would carry and deliver, and the written legal opinion identifying the Act’s provisions said to permit it. Require a transparent schedule of all payments and recipients, consent forms, donor provenance, storage instructions and risk allocation. If any of those answers is missing, avoid paying non-refundable deposits or arranging embryo shipment. For an overseas route, add local counsel’s written opinion, birth-registration pathway, anticipated parentage documents and a pre-cleared nationality and return-document plan. These requests are due-diligence steps, not statutory filing requirements for obtaining surrogate approval.
Which authorities matter and when to seek a written answer
The Ministry of Health and Welfare is the central competent authority under Article 3; the Health Promotion Administration publishes materials on assisted reproduction and licensing. Licensed institutions must still comply with substantive treatment conditions. Questions about licences and whether a described medical step is authorised should be put in writing to the competent health authority, with the actual treatment plan rather than a marketing phrase. Questions about civil-status registration should be directed to the relevant household registration office, and court-dependent parentage issues to qualified local counsel. For conduct involving potential criminal or professional sanctions, request assessment by Taiwanese counsel before proceeding, not a generic verbal assurance from a broker.
A practical stop/go sequence
First, establish the actual location of each act: gamete collection, embryo creation, storage, transfer, pregnancy, delivery and registration may happen in different places. Second, check whether the proposed carrier is the intended mother or a different person; that fact changes the entire Taiwanese statutory analysis. Third, distinguish donation of eggs or sperm from remuneration for pregnancy. Fourth, request the medical institution’s permission and a provision-by-provision explanation. Fifth, obtain independent advice on parentage and child documents before signing or paying. Sixth, document any refusal or adverse administrative decision and obtain advice on the correct complaint or court route. Do not label an unverified route “legal” merely because individual components seem routine.
Examples showing where the line lies
Example A: an eligible married couple uses authorised IVF and the wife carries the pregnancy. This is potentially within the Act, subject to the statutory and clinical conditions; it is not surrogacy. Example B: the couple proposes transferring its embryo to the wife’s sister without any carrier fee. The absence of payment does not create a Taiwanese gestational-carrier programme. Example C: a broker quotes a single price covering donor eggs, embryo creation and a carrier’s services. Examine each element separately; the express rules on profit-motivated gamete dealing may become relevant, but do not attribute all components to the same offence without facts. Example D: the child is born abroad under a local court order; Taiwanese recognition remains an independent issue.
If the clinic or registrar refuses
Do not try to solve a refusal by rewriting the same arrangement as “donation”, “volunteer birth” or an ordinary IVF cycle. Obtain the refusal in writing, identify the authority and legal ground, and preserve the application record and supporting documents. An administrative challenge, civil-status correction or judicial application can have different competent bodies, limitation periods and evidence rules; this page does not assume one universal remedy. Ask local counsel to identify the exact procedure and deadline from the actual decision. If a child already exists, urgent protection of the child’s documentation and care must be evaluated separately from allegations about the adults’ conduct.
Bottom line and remaining checks
As of 25 October 2026, the official Assisted Reproduction Act and relevant public legislative materials support a firm practical conclusion: do not market or proceed with a domestic Taiwanese commercial or altruistic surrogacy programme as though it is legally approved. That does not decide whether every conversation, reimbursement, foreign contract or adult participant is criminally liable. It also does not supply a universal answer for recognition of a child born abroad. Before acting, verify that the statutory text and commencement position have not changed, obtain a Taiwanese-law opinion based on the proposed steps, and secure separate written plans for parentage, registration and travel.
Official sources and interpretation limits
- Taiwan Assisted Reproduction Act, official national law database
- Ministry of Health and Welfare: Executive Yuan reform proposal of 11 December 2025
- Legislative Yuan joint committee meeting, 16 July 2026
- Taiwan Civil Code, official national law database
- Central News Agency: 16 July 2026 joint committee decision to decouple surrogacy
- Ministry of Justice administrative interpretation, 31 July 2026, No. 11503507260
- Legislative Yuan official bill record for the Executive Yuan’s Assisted Reproduction Act amendment








